high

Huawei Unveils Fully Upgraded AI-Centric Xinghe Intelligent Network, Accelerating Intelligent Transformation Across Industries

SHANGHAI, Sept. 19, 2025 /PRNewswire/ -- During HUAWEI CONNECT 2025, Huawei hosted the data communication innovation summit themed "Xinghe Intelligent…

4 days ago

All-Scenario Grid Forming Technology, Accelerating Wind and Solar as Main Power

SHENZHEN, China, Sept. 18, 2025 /PRNewswire/ -- The 3rd International Digital Energy Expo (IDEE) officially kicks off in Shenzhen today, bringing…

4 days ago

Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR®…

5 days ago

Aeluma Announces Proposed Public Offering of Common Stock

September 17, 2025 16:02 ET  | Source: Aeluma, Inc. GOLETA, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ:…

1 week ago

New names set high standards for safety: Togg and firefly shake up the EV market

LEUVEN, BELGIUM – The chances are you won’t have heard of it and will never have seen one of its…

2 weeks ago

CATL Launches Shenxing Pro, Europe’s Optimal Solution for E-Mobility at IAA Mobility 2025

MUNICH, Sept. 7, 2025 /PRNewswire/ -- At CATL Open Day, the company unveiled Shenxing Pro, the world's first lithium iron…

3 weeks ago

ACKO Launches Support Initiative to Help Vehicle Owners Book HSRP Plates Before Maharashtra’s Extended Deadline

BENGALURU, India, Sept. 6, 2025 /PRNewswire/ -- The Maharashtra government has extended the deadline for installing High Security Registration Plates (HSRP)…

3 weeks ago

Free Mark Cuban Foundation AI Bootcamp Coming to Minneapolis This Fall

MINNEAPOLIS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Mark Cuban Foundation, in partnership with Perficient, will host a no-cost Artificial…

3 weeks ago

Free Mark Cuban Foundation AI Bootcamp Coming to Plano This Fall

PLANO, Texas, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Mark Cuban Foundation, in partnership with Perficient, will host a no-cost…

3 weeks ago

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial

- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society…

4 weeks ago